港股今日表现分化,恒生指数小幅低收。其中中国中药(00570)股价大涨35%,成为市场焦点。这与北向资金趁其股价下跌时出手吸纳有关。
中国中药10月22日一度大涨37%,最高达3.05元,收报2.48元,涨幅35%,前收3.82元。大涨的原因是国药集团以每股4.6港元将其私有化的先决条件于10月18日失效后,中药公司的上市地位得以保留。
面对中药股价大跌,北向资金当日出手大手笔买入,为该股注入增长动力。数据显示,北向资金以约9亿元买入中药,成为其最大买家。中药股价暴涨的情况下,北向资金借机吸纳股份,体现出"低吸"的交易思路。在外资力挺下,中药股价一度反弹至3.05元水平。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.